Form of Amendment No. 1 to Loan AgreementLoan Agreement • May 16th, 2023 • Altamira Therapeutics Ltd. • Pharmaceutical preparations
Reference is made to the Loan Agreement dated December 28, 2022 (the “Agreement”), between you (the “Lender”) and Altamira Therapeutics Ltd. (the “AMTL”). The parties hereby agree that, effective as of the date hereof, the Agreement shall be amended as follows:
Amendment No. 6 to Convertible Loan AgreementConvertible Loan Agreement • May 16th, 2023 • Altamira Therapeutics Ltd. • Pharmaceutical preparations
Reference is made to the Convertible Loan Agreement dated February 4, 2022, as amended on January 26, 2023, March 9, 2023, March 23, 2023, March 27, 2023, and April 3, 2023 (the “Agreement”), between FiveT Investment Management Ltd. (the “Lender”) and Altamira Therapeutics Ltd. (the “AMTL”). The parties hereby agree that, effective as of the date hereof, the Agreement shall be amended as follows:
Amendment No. 2 to Loan AgreementLoan Agreement • May 16th, 2023 • Altamira Therapeutics Ltd. • Pharmaceutical preparations
Reference is made to the Loan Agreement dated September 9, 2022 (the “Agreement”), as amended on April 6, 2023, between FiveT Investment Management Ltd., Dominik Lysek and Thomas Meyer (the “Lenders”) and Altamira Therapeutics Ltd. (the “AMTL”). The parties hereby agree that, effective as of the date hereof, the Agreement shall be amended as follows:
